The invention provides improved agents and methods for treatment of diseases associated with beta amyloid (Aß). Preferred agents include antibodies, e.g., humanized antibodies specific for Aß.
AMYLOID BETA ANTIBODIES FOR USE IN IMPROVING COGNITION